AboutHema Bisarya

As director of pediatrics on Sg2’s Intelligence team, Hema leverages more than a decade of experience to provide strategic thought leadership for children’s hospitals and pediatric programs across the country. Her expert insights range from emerging trends impacting pediatric service lines to improving health care quality for children to custom intelligence on market-specific opportunities for key clients. She contributes visionary ideas to Sg2’s webinars and publications on important industry trends, as well as consulting engagements helping organizations optimize pediatric services growth and performance.

Hema is a skilled presenter with international experience presenting at large industry meetings, such as the Pediatric Academic Societies and European Quality Assurance Forum. She is also a proficient facilitator frequently leading discussions with children’s hospital executive leadership and physician leaders.

Prior to joining Sg2, Hema worked at Pascal Metrics, a patient safety organization, implementing real-time harm detection software. At the Children’s Hospital Association, a national alliance of pediatric providers, she focused on measuring quality and safety, improving performance, creating novel and practical solutions through strategic partnerships, and fostering knowledge development. While there, she developed 4 pediatric-focused harm-detection trigger tools for inpatient, neonatal intensive care and pediatric critical care populations.

Hema received a master in health services administration from the University of Kansas Medical Center and earned a bachelor of science with honors in human physiology and biochemistry from the University of London. She is a registered dietitian and has certified training in the Lean Six Sigma methodology. With her family, she sponsors education for orphans through SOS Children’s Villages and supports learning development for blind children in India.

"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."

As of February 11, 2016, Vizient, Inc. has completed its purchase of MedAssets Sg2 and spend and clinical resource management segments from Pamplona Capital Management, LLC. MedAssets revenue cycle business will continue to operate as a wholly-owned subsidiary of Pamplona Capital Management LLP.

Follow Sg2 on Facebook Follow Sg2 on Twitter Connect with Sg2 on LinkedIn Watch Sg2 on YouTube